Endothelin, the kidney, and hypertension

Joey P Granger1, Sean Abram, David Stec

  • 1Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 North State Street, Jackson, 39216-4505, USA. jgranger@physiology.umsmed.edu

Insights

The kidneys regulate blood pressure, but defects in the pressure-natriuresis relationship are common in hypertension. This review explores how the renal endothelin system impacts blood pressure control.

Area of Science:

  • Nephrology
  • Cardiovascular Physiology
  • Endocrinology

Background:

  • Kidneys are crucial for long-term blood pressure regulation.
  • Hypertension is often linked to a defective pressure-natriuresis relationship.
  • The renal endothelin system's role in hypertension requires further elucidation.

Purpose of the Study:

  • To review recent advances in understanding the renal endothelin system.
  • To highlight the mechanisms by which endothelin receptors modulate pressure-natriuresis.
  • To examine the impact on blood pressure regulation in normal and hypertensive states.

Main Methods:

  • Literature review of recent studies on the renal endothelin system.
  • Analysis of endothelin type A and type B receptor activation pathways.
  • Examination of pressure-natriuresis in physiological and pathophysiological conditions.

Main Results:

  • The renal endothelin system significantly influences pressure-natriuresis.
  • Endothelin type A and B receptor activation differentially affects renal function.
  • Dysregulation of this system contributes to hypertensive shifts.

Conclusions:

  • The renal endothelin system is a key modulator of blood pressure.
  • Targeting endothelin receptors may offer therapeutic strategies for hypertension.
  • Further research is needed to fully understand its role in diverse hypertensive conditions.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...